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ABSTRACT 
Background:  
Physiotherapists increasingly manage shoulder referrals in place of orthopaedic doctors. 
Better understanding the agreement between these professionals will help inform the 
safety, quality and potential costs of these care models. 
 
Objective: 
To establish the level of agreement between a physiotherapist and an orthopaedic surgeon 
regarding diagnosis, management and corticosteroid injection, in a representative sample of 
orthopaedic shoulder referrals. 
 
Design:   
Blinded inter-rater agreement study.  
 
Method: 
274 public orthopaedic shoulder patients were independently assessed by a physiotherapist 
and an orthopaedic surgeon. Management, subacromial corticosteroid injection, diagnosis 
and investigation decisions were compared using inter-rater reliability statistics.  
 
Results:  
Agreement between the physiotherapist and the orthopaedic surgeon was near perfect for 
surgical versus nonsurgical management (Gwets agreement coefficient AC1=.93, 95%CI: .90-
.93), safety of injection (AC1=.85, CI: .79-.91) and investigations requested (AC1=.87, CI: .83-
.91); substantial for the presence of subacromial pain (AC1=.74, CI: .66-.81) and diagnosis 
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(AC1=.72, CI: .66-.78); and moderate regarding delivery of subacromial corticosteroid 
injection as an immediate treatment (AC1=.48, CI .33-.53), with the physiotherapist less 
inclined to select corticosteroid injection as the first intervention. 
 
Conclusion: 
In this study a physiotherapist with prescribing and injection training made decisions 
analogous to those of an orthopaedic surgeon at initial consultation for orthopaedic 
shoulder pain, including the safe identification of patients for subacromial injection, without 
prior screening of referrals by orthopaedic doctors.  
 
Trial registration: Australia and New Zealand Clinical Trials Registry, number XXXX 
 
Keywords 
shoulder, corticosteroid injection, physiotherapy, orthopaedic 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 1
BACKGROUND 
 
Musculoskeletal disorders are the second largest cause of global disability (Vos et al. 
2012), with prevalence expected to increase as the population ages (Murray et al. 
2012). As publicly funded health services face growing challenges (Australian 
Government Productivity Commission 2011; Department of Health 2006; The Kings 
Fund 2015), orthopaedic screening services increasingly provide early access to 
experienced physiotherapists (Comans et al. 2014; Desmeules et al. 2012; Stanhope 
et al. 2012) for assessment and non-surgical management. As the second to third 
most prevalent musculoskeletal disorder (Parsons et al. 2007; Picavet and Schouten 
2003; Taylor 2005; Urwin et al. 1998), shoulder pain is frequently referred for 
orthopaedic opinion (Buchbinder et al. 2013; Dorrestijn et al. 2011; Linsell et al. 
2006) and often seen by physiotherapists in screening services (Queensland Health 
2013) where decisions made by physiotherapists, rather than medical doctors, 
determine patient care. Consequently, information is needed about the level of 
similarity between physiotherapist and orthopaedic surgeon decisions, to better 
understand the safety, service quality and potential costs of emerging models of care 
in which patients are seen by physiotherapists instead of medical doctors.   
 
Prior comparisons of physiotherapist and orthopaedic surgeon decision-making only 
partially represent emerging models of care, as they focused on less complex 
patients and neglected prescribing and corticosteroid injection. Physiotherapists and 
orthopaedic surgeons generally agree on hip and knee diagnosis and management 
(Aiken et al. 2008; Aiken and McColl 2008; Desmeules et al. 2013; MacKay et al. 
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2009), however all but one study (Aiken et al. 2008) excluded patients with higher 
comorbidity or complexity. Only two studies have investigated shoulder pain; one 
had only six shoulder participants (Aiken and McColl 2008), the other reported a 
Kappa of 0.75 for surgical versus conservative management (Razmjou et al. 2013) 
and both excluded more complex cases with suggestion of infection, metabolic or 
inflammatory disease, masses, compensation claims or previous surgery. Therefore, 
no studies have yet compared the shoulder management decisions of a 
physiotherapist with those of an orthopaedic surgeon, across the range of 
presentations that might normally attend an orthopaedic outpatient clinic. This 
knowledge gap has important application to service design, regarding whether it is 
necessary for an orthopaedic doctor to review referrals to select which patients will 
be seen by a physiotherapist. A further knowledge gap relates to corticosteroid 
injection, a common non-surgical treatment for the most prevalent form of shoulder 
pain caused by subacromial pathologies (Diercks et al. 2014; Hambly et al. 2007; 
James et al. 2005; Jowett et al. 2013). Presently physiotherapists are only permitted 
to train in prescribing and injection in the UK (UK Government 2013), with similar 
models under investigation in some other countries (Health Workforce Australia 
2013). No studies have yet investigated prescribing and injection decisions of 
medical doctors compared with physiotherapists trained in these procedures.    
 
Therefore, we compared decisions made by a physiotherapist and a consultant 
orthopaedic surgeon in a representative sample of adult shoulder pain referred by 
general practitioners to hospital orthopaedics. Primary aims were to assess 
agreement regarding patient management, selection for subacromial corticosteroid 
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injection and injection safety, and describe the reasoning underpinning decision 
discrepancies. Secondary aims were to describe the level of diagnostic and 
investigation agreement. 
 
METHODS 
Design 
A blinded inter-rater decision-making reliability study, as described in the published 
randomised controlled trial (RCT) protocol (Marks et al. 2014) investigating the 
outcomes of subacromial corticosteroid injection delivered by a physiotherapist 
compared with an orthopaedic surgeon, was undertaken on the Gold Coast, 
Australia between January 2013 and June 2014. Agreement between the 
physiotherapist and orthopaedic surgeon was an inclusion criteria for the RCT and 
we have separated the inter-rater decision-making analysis from the RCT to enable 
it’s full reporting. Other elements within this published protocol are reported 
separately. All participants provided written informed consent and were able to 
withdraw from the study at any point without impact upon their care.  
 
Ethical approval 
Ethical Approval was granted through the Gold Coast Hospital and Health Service 
Human Research Ethics Committee, NHMRC code EC00160 (HREC/12/QGC/30; 
SSA/12/QGC/97), and Griffith University Human Research Ethics Committee 
(MED/23/13/HREC). The trial was registered on the Australia and New Zealand 
Clinical Trials Registry 21 May 2012: 12612000532808 
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Participants 
Adults aged 18 years or over with a new orthopaedic shoulder referral from a 
general practitioner (GP) were recruited from the waiting list, if they were able to 
read and understand the trial literature and provide informed consent, and excluded 
if they knew the assessing physiotherapist or orthopaedic surgeon (eg, from previous 
consultation) or had not received a plain radiograph (X-Ray) of their affected 
shoulder in the previous 12 months (in keeping with local referral guidelines).  
 
Assessors 
The physiotherapist (DM) had 19 years musculoskeletal experience including 
qualifications in injection therapy and UK Non-Medical Prescribing. The orthopaedic 
surgeon (MT) was a staff specialist with 20 years of experience and a Fellow of the 
UK Royal College of Surgeons.  
 
Centres 
All participants were seen in orthopaedic outpatient settings, at Gold Coast Hospital 
and Health Service, Australia.  
 
Intervention (clinical assessments) 
After the research assistant gained consent, all participants were independently 
examined the physiotherapist and the orthopaedic surgeon in variable order 
according to assessor availability. Patients were allocated 30 minutes with each 
assessor with the same information; the orthopaedic referral, the electronic hospital 
record, shoulder X-ray report, other results such as diagnostic imaging films and/or 
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reports (MRI, CT, ultrasound scans) or pathology results that participants brought to 
the consultation. Each assessor performed a clinical assessment (history and physical 
examination) and completed a standardised assessment form for each participant, 
which was returned to the research assistant upon completion.  
 
Blinding 
Participants were blind to the profession of their assessors (i.e. they did not know 
which clinician was the physiotherapist and which was the surgeon), and were 
unaware of the clinical decisions of the assessors until all assessments had been 
completed. Assessors consulted with participants independently, in separate rooms 
and were blind to each other’s findings. 
 
Outcome measures 
Participant characteristics collected by the research assistant prior to assessment 
included demographics, symptom duration, the Shoulder Pain and Disability Index 
(SPADI) which is a reliable and valid self-rating tool for people with shoulder pain 
(Angst et al. 2011; Roach et al. 1991); the worst shoulder pain severity over the past 
three days via a 100 mm visual analogue scale (VAS; 0 = no pain, 100 = worst pain 
imaginable); and the European Quality of Life five dimensions, five levels (EQ-5D-5L), 
converted to Australian values (Norman, Cronin, and Viney 2013). Assessors 
recorded their findings and clinical decisions on the paper assessment form. The 
research assistant was responsible for entry of data into the electronic database and 
coding of free text into categories for analysis. 
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Primary outcomes investigated management and subacromial corticosteroid 
injection decisions made by each assessor. Management was recorded in two ways: 
dichotomous response (yes / no) to the question “is it appropriate to have initial 
non-surgical care?”, and by free text “proposed management plan” responses. 
Subacromial corticosteroid injection decisions were investigated with dichotomous 
(yes / no) assessor responses to three questions focusing on different considerations 
within an injection decision: safety, “is it safe to offer injection today?”; whether 
there is symptomatic indication for the injection, “do clinical findings support the use 
of subacromial injection?”; and whether injection is the immediate treatment 
priority, “would you provide subacromial injection today?”.  Assessors also recorded 
reasons for not offering same-day injection via free text and under categories of 
safety, consent, other priority, need for prior investigation, or other.  
 
Secondary outcomes were diagnoses and radiology or pathology investigations 
recorded in free text. Diagnoses were assigned to one of eight categories by the 
research assistant (if multiple contributory diagnoses were recorded, the first or 
primary diagnosis was used): 1. subacromial impingement syndrome (SAIS, SIS, 
bursitis), 2. glenohumeral osteoarthritis, 3. acromioclavicular osteoarthritis, 4. 
adhesive capsulitis, 5. rotator cuff tear (distinguished by it being listed above any 
other factors or requiring surgical repair), 6. long head of biceps symptoms, 7. 
instability and / or labral pathology, and 8. pain from non-shoulder origin (including 
cervical referred, systemic inflammatory disorders, neurological or sensory 
disorders). 
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Sample size 
Sample size calculations for the randomised controlled trial within the published 
protocol (Marks et al. 2014), assumed α = 0.05 and power = 0.8 (80%), with a sample 
of 64 participants required for the RCT. We anticipated that 25% of all participants 
assessed, would enter the RCT. As all assessed participants would be eligible for the 
present agreement study, 256 were expected and 274 participants were ultimately 
recruited. This number exceeds the largest number of subjects (n=100) previously 
reported by an inter-rater orthopaedic and physiotherapy agreement study 
(Razmjou et al. 2013). It also exceeds the number required to detect Kappa values 
over 0.6 with 90% power, assuming a null of Kappa = 0.4 (Sim and Wright 2005), and 
the number required for agreement proportions of 30% to 100%, with a relative 
error of 20% (Gwet 2010).  
 
Data analysis 
Data were analysed using SPSS software version 22 (IBM, Chicago USA), AgreeStat 
2013.4, and AgreeStat 2015.5 for Excel (Advanced Analytics; Gaithersburg, MD, 
USA). Accuracy of the free text coding was assessed by two investigators (DM, LB), 
and at the completion of data entry the accuracy of the data entries ensured 
through comparison of the hard copy data and the data on the electronic database 
for 30 participants (every tenth participant), by one investigator (DM). Descriptive 
statistics were used to describe baseline characteristics. Four agreement coefficients 
were calculated for primary and secondary outcomes, to assess the level of 
agreement (inter-rater reliability) between the physiotherapist and the orthopaedic 
surgeon: Cohen’s Kappa (Sim and Wright 2005), prevalence and bias adjusted Kappa 
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(PABAK) (Sim and Wright 2005), Gwet’s first order agreement coefficient (AC1) 
(Gwet 2012), and percentage agreement. For free text “proposed management 
plan” responses, frequencies were calculated and presented descriptively. 
Descriptive analysis of disagreements was also undertaken.  
 
Kappa is commonly used for inter-rater agreement calculations (Gwet 2012; Sim and 
Wright 2005), yet its paradoxes are known to cause low values in the presence of 
high observed agreement (Cicchetti and Feinstein 1990). To overcome this we used 
PABAK and Gwet’s AC1 which both provide different alternative calculations for the 
agreement by chance (Gwet 2012). PABAK removes bias by bringing the expected 
agreement to an average value of 0.5 and should be interpreted alongside Cohen’s 
Kappa (Sim and Wright 2005) and individual cell data (Chen et al. 2009). Gwet’s AC1 
removes the agreement by chance (Gwet 2012) and has been recommended for its 
stability in the presence of high inter-rater agreement (Wongpakaran et al. 2013). As 
previous shoulder inter-rater agreement studies used Kappa and PABAK (Razmjou et 
al. 2013), or Kappa with percentage agreement (Aiken and McColl 2008), we have 
presented the four measures, to both aid comparison with previous research and to 
demonstrate the consistency of our findings with the different measures. We applied 
the following established scale (Landis and Koch 1977) to the interpretation of the 
magnitude of Kappa and AC1 values: <0.2 poor, 0.21 - 0.4 fair, 0.41 - 0.6 moderate, 
0.61 - 0.8 substantial, 0.81 – 1 near perfect agreement.  
 
RESULTS 
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988 orthopaedic referrals were screened for eligibility by the research assistant 
according to the published protocol (Marks et al. 2014). Of 305 attending between 
January 2013 and June 2014, 278 met the inclusion criteria. Three did not complete 
assessment at completion of the RCT protocol, and one participant with bilateral 
shoulder pain was excluded as the assessors each examined different shoulders. This 
left 274 participants who were examined by the physiotherapist and the orthopaedic 
surgeon, their characteristics are described in Table 1.  
 
Table 1. Participant characteristics (n=274) 
Age years, mean (SD)  57.9 (13.0) 
Gender female % 49.0 
Duration of shoulder symptoms months, mean (SD) 21.7 (36.5) 
Undertaking paid employment % 53.6 
Total SPADI score /100, mean (SD)  58.3 (22.9) 
Worst pain last 3 days 100mm VAS, mean (SD) 61.4 (25.0) 
EQ-5D-5L health utility score, mean (SD)  0.50 (0.29) 
 
Primary Outcomes 
Management decisions: 
There was near perfect agreement regarding initial management with surgery versus 
non-surgical care (Table 2), with the artificially low Cohen’s Kappa (.28) a result of 
prevalence bias from high non-surgical agreement at 253 / 274 (Table 3). In the eight 
cases in which the surgeon said no to initial non-surgical care but the physiotherapist 
said yes, the physiotherapist also recommended orthopaedic review for surgery in 
four cases, and MRI in the other four. Conversely in nine cases the physiotherapist 
felt orthopaedic review was needed and said no to initial non-surgical care but the 
surgeon said yes. In seven of these the surgeon opted for corticosteroid injection 
and recorded that surgery would be likely if response to injection was insufficient. In 
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the remaining two cases the surgeon wanted to trial physiotherapy initially.  
Physiotherapy was the most frequent treatment recommendation by both assessors 
(223/ 274 cases). Overall, the physiotherapist recommended physiotherapy 
treatment in 86% of cases, and the surgeon in 91% of cases.  
 
Table 2: Calculated agreement coefficients for the level of agreement between the 
physiotherapist and orthopaedic surgeon 
 
Cohen’s Kappa PABAK AC1  
%  
agreement 
Value 
(SEM) 
95% CI 
Value 
(SEM) 
95% CI 
Value 
(SEM) 
95% CI 
Initial management*
 
.28 (0.1) .04-.53 .87 (.03) .81-.93 .93 (.02) .90-.93 94 
Safety of injection#
 
.65 (.06) .53-.76 .78 (.04) .71-.86 .85 (.02) .79-.91 89 
Subacromial pain$
 
.43 (.06) .31-.56 .64 (.04) .55-.73 .74 (.03) .66-.81 82 
Same-day inject^
 
.42 (.05) .32-.53 .45 (.05) .39-.55 .48 (.05) .33-.53 72 
Investigations&
 
.52 (.07) .38-.66 .85 (.02) .80-.90 .87 (.02) .83-.91 88 
Diagnosis+ .53 (.05) .44-.62 .70 (.03) .64-.76 .72 (.03) .66-.78 74 
*Initial management (surgical / non-surgical) 
# $ ^ Categories: Yes / No 
& Nil, XRay, MRI, CT scan, blood tests 
+ Diagnostic categories: 1. Subacromial impingement syndrome, 2. Glenohumeral 
osteoarthritis, 3. Acromioclavicular osteoarthritis, 4. Adhesive capsulitis, 5. Rotator cuff tear, 
6. Long head biceps symptoms, 7. Instability / labral pathology, 8.Pain from non-shoulder 
origin. 
Subacromial pain = clinical findings support the use of subacromial injection 
SEM = standard error of the mean; CI = confidence interval, PABAK = prevalence and bias 
adjusted Kappa, AC1 = Gwet’s first order agreement coefficient. 
 
 
 
Table 3:  Management: “is it appropriate to have initial non-surgical care?” 
P
h
y
si
o
th
e
ra
p
is
t  Orthopaedic Surgeon 
 Initial non-surgical Surgical Total 
Initial non-surgical 253 8 261 
Surgical 9 4 13 
 
Total 
 
262 
 
12 
 
274 
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Injection decisions: 
There was substantial to near perfect agreement regarding whether it was safe to 
inject (Table 2).  Of the 36 cases in which the surgeon felt it was unsafe to inject on 
the day of assessment, the physiotherapist reached the same conclusion in 35 (Table 
4). In the one remaining case, the patient reported being well but test results from 
recent endoscopy were not available on the day of assessment. The physiotherapist 
rated this as a precaution rather than a contraindication to injection.  Conversely in 
28 cases the physiotherapist perceived a safety barrier yet the surgeon felt it would 
be safe to inject. The physiotherapist’s reasons were; the possibility of a concurrent 
infection (such as skin, dental, urinary or other) needing further medical review 
before injection (N=20), possible need for prophylactic antibiotics prior to injection 
due to a prosthetic heart valve (N=3), history of possible fracture (N=2), and poor 
diabetic control (N=1).  
 
Table 4: Injection decisions 
 Orthopaedic Surgeon 
P
h
y
si
o
th
e
ra
p
is
t 
Is it safe to inject today? 
 Yes No Total 
Yes 210 1 211 
No 28 35 63 
Total 238 36 274 
Subacromial symptoms present? 
 Yes No Total 
Yes 197 42 239 
No 7 28 35 
Total 204 70 274 
Would you provide subacromial injection today? 
 Yes No Total 
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Yes 66 14 80 
No  62 132 194 
Total 128 146 274 
  
 
There were substantial levels of agreement on the presence or absence of symptoms 
to support the use of subacromial injection (Table 2). Again prevalence bias lowers 
Cohen’s Kappa to .43 because of a high incidence of agreement between assessors 
(table 4) on the presence of subacromial symptoms (197/274 cases).  
 
Table 2 reveals moderate agreement regarding same-day delivery of subacromial 
corticosteroid injection. In most cases assessors agreed to provide, or not provide, 
same day injection (Table 4). There were 14 cases of disagreement, in which the 
physiotherapist said yes and surgeon said no. The surgeon’s reasons were: eight 
cases of dual pathology in which the surgeon chose to inject another structure over 
the subacromial space as first priority (long head of biceps sheath in six cases, 
acromioclavicular joint in two cases); in four cases the surgeon referred for initial 
physiotherapy; and two cases the surgeon requested MRI in the first instance.  
Conversely there were 62 cases in which the surgeon opted to provide same-day 
subacromial injection but the physiotherapist did not. A detailed breakdown of the 
reasons is contained in Table 5. 
 
Table 5: Physiotherapist reasons for not choosing same-day subacromial injection, when 
the surgeon did chose to deliver same day subacromial injection. 
 
Physiotherapist decision No. Reason provided by physiotherapist (number of cases) 
Physiotherapy treatment 
is higher priority 
17 Spine +/- shoulder physiotherapy treatment (10) 
Shoulder physiotherapy treatment (7) 
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Safety concerns prevent 
injection on the day 
15 Symptoms of unrelated infection for medical review (12) 
Patient unable to supply names of a drug being used (1) 
Prophylactic antibiotic consideration-prosthetic cardiac valve (1) 
Allergic skin reaction to another agent already present (1) 
Orthopaedic review 
needed prior to an 
injection 
 
13 Cuff tear for MRI +/- surgical consideration (7) 
MRI shoulder due to diagnostic uncertainty (4) 
MRI cervical spine (1) 
Stable shoulder fracture present, for orthopaedic opinion (1) 
Presentation not likely to 
respond to subacromial 
injection 
5 Significant rotator cuff tear (2) 
Long head of biceps pain source (1) 
Osteoarthritis too significant (1) 
Cervical spine cause (1) 
Other injection is higher 
priority 
5 Long head of biceps sheath (5) 
Consent not gained 4 Patient declined injection when offered by physiotherapist (4) 
Possible inflammatory 
pathology 
3 Blood tests +/- rheumatology referral (3) 
 
 
Secondary Outcomes 
Investigation requests revealed near perfect agreement (AC1=.87) by type (Table 2), 
and similar volume (Table 6). In 220 cases both assessors agreed that no further 
investigations were required. Overall the physiotherapist recommended no further 
investigation in 226 cases, the surgeon in 245. The physiotherapist recommended 
MRI in 42/274 (15%) of cases, the surgeon in 28/274 (10%). In 22 out of the 28 cases 
both requested MRI, and in four of these cases both assessors requested an MRI and 
CT scan simultaneously for arthroplasty planning. The physiotherapist recommended 
MRI in another 20 other cases when the surgeon didn’t, however in half of these 
cases the surgeon’s plan was to review in six weeks and progress to MRI or surgery if 
initial management had not been successful.  
 
Table 6: Investigations requested by each assessor 
       Orthopaedic Surgeon 
P
h
y
si
o
t   Nil XRay MRI CT Scan Bloods Total 
Nil 220 1 5 0 0 226 
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XRay 2 0 1 0 0 3 
MRI 20 0 22 0 0 42 
CT 1 0 0 4 0 5 
Bloods 2 0 0 0 0 2 
Total 245 1 28 4 0  
All participants attended with an XRay report of the painful shoulder less 
than 12 months old. 
 
 
Diagnosis: 
Overall, there was substantial agreement (AC1=0.72) between the two assessors on 
categorised primary shoulder pain diagnoses (Table 2). The frequencies with which 
each assessor recorded primary diagnoses in each of the eight diagnostic categories, 
and the agreement between assessors are detailed in Table 7. Subacromial 
impingement was the most common primary diagnosis, made by the orthopaedic 
surgeon in 188 cases, the physiotherapist in 170 cases, with agreement in 148 cases. 
Other primary diagnoses were recorded less frequently, with varying levels of 
agreement as detailed in Table 7.  
 
Table 7: Diagnosis made by each assessor  
 
Orthopaedic Surgeon 
P
h
y
si
o
th
e
ra
p
is
t 
Category  1 2 3 4 5 6 7 8 Total 
1 148 1 3 3 6 6 1 2 170 
2 2 8 0 0 0 0 0 0 10 
3 4 1 7 0 0 1 0 0 13 
4 4 0 0 12 0 0 0 0 16 
5 6 0 0 0 7 0 0 0 13 
6 9 1 0 0 1 5 0 0 16 
7 3 0 0 0 0 0 2 0 5 
8 12 0 3 0 0 1 1 13 30 
 
Total 188 11 13 15 14 13 4 15 273 
 
Categories 1. Subacromial impingement syndrome, 2. Glenohumeral 
osteoarthritis, 3. Acromioclavicular osteoarthritis, 4. Adhesive capsulitis, 
5. Rotator cuff tear, 6. Long head biceps symptoms, 7. Instability / labral 
pathology, 8.Pain of non-shoulder origin. 
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DISCUSSION 
Results demonstrate that the physiotherapist makes safe and very similar decisions 
to the orthopaedic surgeon in relation to care delivery, prescription of corticosteroid 
injection, investigation and diagnosis. These findings provide preliminary support for 
agreement between these two professions and have relevance to models of care 
which complement or substitute medical doctors with physiotherapists to improve 
access for patients, service productivity and workforce shortages (Brooks, Robinson, 
and Ellis 2008; Comans et al. 2014; Duckett 2005). In previous studies orthopaedic 
doctors first screened referrals to exclude more complex patients and/or those 
thought more likely to need surgery (Aiken and McColl 2008; Bornhöft, Larsson, and 
Thorn 2015; Daker-White et al. 1999; Ludvigsson et al. 2011; MacKay et al. 2009; 
Samsson and Larsson 2014; Weale and Bannister 1995). We did not exclude more 
complex referrals and therefore our results indicate that an experienced 
physiotherapist can safely and appropriately manage the breadth of GP orthopaedic 
shoulder referrals, suggesting that screening of referrals by orthopaedic doctors 
prior to physiotherapist assessment may be unnecessary.  
 
Previously physiotherapists have more frequently recommended education and 
physiotherapy exercises than orthopaedic doctors (Aiken et al. 2008; Daker-White et 
al. 1999; Desmeules et al. 2013), yet we found near perfect agreement and minimal 
overall difference in the rate of referral to physiotherapy. Our findings of lower 
injection recommendation rates by the physiotherapist contrast with two previous 
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studies (Desmeules et al. 2013; Razmjou et al. 2013). However, ours is the first study 
to investigate this with a physiotherapist qualified to inject and prescribe. 
Agreement was near perfect regarding the safety aspects of injection and substantial 
regarding the presence of subacromial symptoms. Whilst still moderate, agreement 
was less regarding whether to deliver an immediate injection, with 14/274 cases in 
which the physiotherapist chose to inject but the surgeon did not, and 62/274 cases 
in which the surgeon chose to immediately inject but the physiotherapist did not; 
few of which were due to disagreement about whether the presentation may be 
amenable to subacromial injection, but rather reflected different prioritisation of 
non-surgical treatment options, with the physiotherapist less inclined than the 
surgeon to start with corticosteroid injection (Table 5). We consider this more 
conservative approach to injection by the physiotherapist to be appropriate, and 
further research could establish whether this finding is a consistent feature of 
physiotherapy prescribing / injection practice.  
 
This study has some limitations. Generalizability is limited with just one orthopaedic 
surgeon and one physiotherapist. While this is consistent with previously published 
shoulder decision-making comparisons (Aiken and McColl 2008; Razmjou et al. 
2013), it means that specific findings may have limited generalizability beyond this 
study. The use of only one physiotherapist was due to the study protocol (Marks et 
al. 2014) including injection by a physiotherapist (reported separately), and as this is 
not normally permitted in Australia, additional qualified physiotherapists were not 
available. Future research with more professionals could verify our findings. 
Furthermore, intra-professional decision-making has not previously been reported, 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 17
and this could provide a more robust basis for inter-professional comparison. A 
second limitation was the exclusion of participants without a reported X-Ray less 
than 12 months old. This met departmental referral requirements and helped 
prevent clinic delays but also reduced the need for assessors to interpret unreported 
imaging. Thirdly, we were unable to formally randomize the order of the participant 
examination (physiotherapist or surgeon first) due to the practicalities of room 
availability in an outpatient clinic setting. Instead, participants were pseudo-
randomized according to which health practitioner was first available at the time of 
their appointment. Whilst appointments were allocated on a 30-minute basis, we did 
not record actual consultation times. A final limitation is that the collection of follow-
up clinical outcomes was beyond the scope of the present study. This data could 
provide further insight, particularly in cases of assessor disagreement.  
 
In conclusion, this study compared one experienced physiotherapist qualified in 
prescribing and corticosteroid injection, with one orthopaedic surgeon and found 
near perfect agreement between the two regarding clinical decision making 
(investigation, surgical or non-surgical management and subacromial corticosteroid 
injection safety) for shoulder patients referred to an Australian public hospital 
orthopaedic department. There were differences in the priority given to different 
non-surgical treatment options, with a more conservative approach by the 
physiotherapist regarding subacromial corticosteroid injection as the first and 
immediate treatment. This study suggests that screening of referrals by orthopaedic 
doctors prior to assessment by a suitably qualified physiotherapist may be 
unnecessary, and found no clinical, safety or cost basis for legislative or funding 
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policy impediments to appropriately trained physiotherapists selecting and referring 
shoulder pain patients for subacromial corticosteroid injection.  
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Highlights: 
• 274 orthopaedic shoulder patients were examined 
• A physiotherapist and a surgeon made analogous shoulder management decisions  
• The physiotherapist less frequently recommended corticosteroid injection  
• Vetting of referrals by orthopaedic doctors appears unnecessary  
